EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

43 hedge funds and large institutions have $4.17M invested in Eiger BioPharmaceuticals, Inc. in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
43
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$77K
2
+$6K
3
+$4.81K
4
Jane Street
Jane Street
New York
+$3.32K
5
Prudential Financial
Prudential Financial
New Jersey
+$2.69K

Top Sellers

1
-$824K
2
-$244K
3
-$123K
4
UOC
UBS O'Connor
Illinois
-$120K
5
GCP
GSA Capital Partners
United Kingdom
-$109K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4.11K
27
$3.25K
28
$2.69K
29
$2.48K
30
$2.25K
31
$2K
32
$1.85K
33
$661
34
$652
35
$522
36
$301
37
$90
38
$83
39
$69
40
$39
41
$37
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3